4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Drugs Made In America Acquisition Corp. (DMAA) operates in the Shell Companies industry and is headquartered in New York, United States. Its market capitalization is roughly $259 million. In the fiscal year ended 2025-12-31, DMAA reported $0M in revenue and $6M in net income.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp.
Interactive charts & full statements →
| Income statement | 2025-12-31 |
|---|---|
| Total Revenue | $0M |
| Operating Income (EBIT) | ($3M) |
| Net Income | $6M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($0M) | ($2M) | ($0M) | ($0M) | ($0M) |
| Net Income | $2M | $0M | $2M | $2M | $1M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total Assets | $240M | $1M |
| Total Liabilities | $7M | $1M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive DMAA viewer.
About TickerBase · Data methodology & sources